Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00565695 · ClinicalTrials.gov registry record
Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction
A clinical trial of Cataract Extraction and Refractive Surgery, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT00565695: Completed study of Cataract Extraction and Refractive Surgery, sponsored by Medical University of South Carolina.
NCT00565695 is a study of Cataract Extraction and Refractive Surgery that has completed, run by Medical University of South Carolina. The registered enrollment target is 20 participants, below the 102-participant average among 4 other Cataract Extraction trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00565695, a study of Cataract Extraction and Refractive Surgery, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the visual outcomes and patient satisfaction after bilateral implantation of the aspheric ReSTOR multifocal intraocular lens (IOL) and compare it to a historical control group of patients implanted bilaterally with the spherical ReSTOR multifocal IOL.
Conditions Studied
Interventions
- DEVICE aspheric ReSTOR multifocal intraocular lens (IOL)
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-10 |
| Est. Completion | 2008-09 |
What the finished NCT00565695 record still lists
NCT00565695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 102-participant average among 4 other Cataract Extraction trials with a reported enrollment target (80% lower).
The record links to 2 conditions, with Cataract Extraction appearing as the primary indexed condition, and to 1 intervention - of which aspheric ReSTOR multifocal intraocular lens (IOL) is the first listed.
NCT00565695 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT00565695 about?
NCT00565695 is a clinical study titled "Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction". The purpose of this study is to evaluate the visual outcomes and patient satisfaction after bilateral implantation of the aspheric ReSTOR multifocal intraocular lens (IOL) and compare it to a historical control group of patients implanted bilaterally with the spherical ReSTOR multifocal IOL.
What is the current status of trial NCT00565695?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2007-10. Estimated completion is 2008-09.
What conditions does trial NCT00565695 study?
This clinical trial studies the following conditions: Cataract Extraction, Refractive Surgery.
What interventions are being tested in trial NCT00565695?
The interventions under investigation include: aspheric ReSTOR multifocal intraocular lens (IOL) (DEVICE).
Who is sponsoring clinical trial NCT00565695?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00565695 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract Extraction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification.
COMPLETED · Phase 1
-
Comparison of Visual Outcomes and Patient Satisfaction After Cataract Surgery and Implantation of ReSTOR and ReZoom IOLs
COMPLETED · Phase 4
-
A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery
COMPLETED · Phase 3
-
Study of Ocular Penetration of Topically Administered Fluoroquinolones
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia